https://www.selleckchem.com/products/sel120.html Moreover, the inflammatory microenvironment created by macrophage/MAO-modified Ti surface interactions could promote the collagen syntheses and matrix mineralization of osteoblast-like cells grown tissue culture plate. When osteoblasts were cultured on MAO-modified Ti surface and cultured by macrophage/MAO-modified Ti surface conditioned medium (CM), the alkaline phosphatase (ALP) activity and collagen synthesis of osteoblast-like cells were promoted. This study suggests that MAO-modified Ti surface is beneficial for osteogenesis at both stages after implantation (before and after osteoblast recruitment to biomaterial surfaces). The use of nanocarriers for drug delivery is a strategy aimed to improve therapeutic indices through changes in their pharmacokinetic and pharmacodynamic characteristics. Liposomes are well-investigated nanocarriers for drug delivery to macrophage-targeted therapy, the main hosts of intracellular pathogens of some infectious diseases, such as leishmaniasis. In this study, we developed hyaluronic acid (HA)-coated liposomes by different methods that can encapsulate a new quinoxaline derivative, the LSPN331, to increase its solubility and improve its bioavailability. The surface modification of liposomes and their physicochemical characteristics may depend on the coating method, which may be a critical parameter with regard to the route of administration of the antileishmanial drug. Liposomes with identical phospholipid composition containing the same drug were developed, and different biological responses were verified, and our hypothesis is that it is related to the type of modification of the surface. Different physicochemical characterization techniques (dynamic light scattering, transmission electron microscopy and UV-vis quantification of labeled-HA) were used to confirm the successful modification of liposomes as well as their stability upon storage. The encapsulation of LSPN331 was perfor